# Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days

> **NCT02099149** · — · WITHDRAWN · sponsor: **Novartis**

## Conditions studied

- Invasive Group B Streptococcus Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02099149
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-05
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099149, "Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02099149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*